Tufts Postdoc Merges Computer Science and Alpaca Immunology in Innovative Study

Will White, a postdoctoral scholar in the Department of Computer Science at Tufts University, has redirected his bioengineering expertise toward an unlikely collaboration with the alpaca immune system. Having earned both a bachelor’s degree and a Ph.D. in molecular biology, White originally expected a path centered on DNA, proteins, and conventional wet‑lab work. Yet his current project blends algorithmic engineering with the distinctive features of alpaca antibodies, forging a fresh interdisciplinary frontier.

Alpacas generate single‑chain antibodies called nanobodies, valued for their robustness and amenability to engineering. In White’s study, machine‑learning methods are employed to forecast nanobody structures and enhance their binding strengths toward therapeutic targets. By inputting extensive alpaca immune‑repertoire datasets into computational models, the team seeks to speed up a design process that ordinarily takes months of laboratory trial and error.

The project exemplifies a wider movement in computational biology that is redefining drug‑discovery strategies. Conventional techniques depend heavily on trial‑and‑error protein screening, a method that is both expensive and time‑intensive. White’s strategy uses high‑performance computing to model molecular interactions, potentially compressing the timeline from idea to candidate molecule.

University representatives point out that the partnership highlights Tufts’ dedication to interdisciplinary research. The computer‑science department supplies skill in algorithm development and data management, whereas the bioengineering faculty offers extensive insight into immunology and protein chemistry. This combined expertise enables the investigation of problems that lie at the crossroads of two historically distinct disciplines.

Going forward, White intends to test his computational forecasts with a suite of laboratory assays, collaborating with biotech companies focused on nanobody therapeutics. Should the effort prove successful, the workflow could become a model for deploying artificial intelligence on other unconventional immune systems, expanding the toolkit for drug developers. This research not only showcases the potential of interdisciplinary science but also demonstrates how a seemingly obscure animal biology can drive cutting‑edge technology.